norfluoxetine has been researched along with Liver Diseases in 1 studies
norfluoxetine: metabolite of fluoxetine; RN given refers to parent cpd without isomeric designation
Liver Diseases: Pathological processes of the LIVER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergstrom, RF | 1 |
| Beasley, CM | 1 |
| Levy, NB | 1 |
| Blumenfield, M | 1 |
| Lemberger, L | 1 |
1 review available for norfluoxetine and Liver Diseases
| Article | Year |
|---|---|
The effects of renal and hepatic disease on the pharmacokinetics, renal tolerance, and risk-benefit profile of fluoxetine.
Topics: Adult; Aged; Clinical Trials as Topic; Depressive Disorder; Dose-Response Relationship, Drug; Drug A | 1993 |